학술논문

Estimating seroconversion rates accounting for repeated infections by approximate Bayesian computation
Document Type
article
Source
Statistics in Medicine. 42(28)
Subject
Epidemiology
Statistics
Health Sciences
Mathematical Sciences
Infectious Diseases
Emerging Infectious Diseases
Infection
Humans
Likelihood Functions
Bayes Theorem
Cross-Sectional Studies
Seroconversion
HIV Seropositivity
approximate Bayesian computation
empirical distribution function
reinfection
seroincidence
Public Health and Health Services
Statistics & Probability
Language
Abstract
This study presents a novel approach for inferring the incidence of infections by employing a quantitative model of the serum antibody response. Current methodologies often overlook the cumulative effect of an individual's infection history, making it challenging to obtain a marginal distribution for antibody concentrations. Our proposed approach leverages approximate Bayesian computation to simulate cross-sectional antibody responses and compare these to observed data, factoring in the impact of repeated infections. We then assess the empirical distribution functions of the simulated and observed antibody data utilizing Kolmogorov deviance, thereby incorporating a goodness-of-fit check. This new method not only matches the computational efficiency of preceding likelihood-based analyses but also facilitates the joint estimation of antibody noise parameters. The results affirm that the predictions generated by our within-host model closely align with the observed distributions from cross-sectional samples of a well-characterized population. Our findings mirror those of likelihood-based methodologies in scenarios of low infection pressure, such as the transmission of pertussis in Europe. However, our simulations reveal that in settings of higher infection pressure, likelihood-based approaches tend to underestimate the force of infection. Thus, our novel methodology presents significant advancements in estimating infection incidence, thereby enhancing our understanding of disease dynamics in the field of epidemiology.